Brief: India's Zim Laboratories March-Quarter Consol PAT Rises
19/05/2023 15:46
May 19 (Reuters) - Zim Laboratories Ltd ZIML.NS :
* MARCH-QUARTER CONSOL PAT 72.4 MILLION RUPEES VERSUS 70.3
MILLION
RUPEES
* MARCH-QUARTER CONSOL TOTAL INCOME 1.06 BILLION RUPEES
VERSUS
1.07 BILLION RUPEES
Further company coverage: ZIML.NS
((Reutersbriefs@thomsonreuters.com;))
Recent news on Zim Laboratories
See all newsBrief: Zim Laboratories Gets Marketing Authorization For Dabigatran Etexilate Capsules In Italy, Europe
Brief: Zim Laboratories March-Quarter Consol Net Profit 37.4 Mln Rupees
Brief: Zim Laboratories To Consider Fund Raising Via Securities Issuance
Brief: Zim Laboratories Gets Marketing Authorization For Tamsulosin + Dutasteride Capsules In Australia
India's Zim Laboratories up after getting marketing authorization for migraine drug in Australia